Although some studies have found that the treatment response seems to be related to PD-L1 expression 8, it has been reported that patients with PD-L1-negative tumors can also respond to treatment, which may be related to limited tissue sampling or the temporal and spatial heterogeneity of the tumor 9. The gene discussed is CD274; the disease is neoplasm.